BAAM
SRPT icon

Baker Avenue Asset Management’s Sarepta Therapeutics SRPT Stock Holding History

Baker Avenue Asset Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-57,238
Closed -$1.23M – 778
2025
Q4 		$1.23M Sell
57,238
-4,825
-8% -$102K 0.03% 246
2025
Q3 		$1.2M Buy
+62,063
New +$1.11M 0.03% 241
2023
Q4 		– Sell
-46
Closed -$5.58K – 1331
2023
Q3 		$5.58K Hold
46
– – ﹤0.01% 914
2023
Q2 		$5.27K Hold
46
– – ﹤0.01% 845
2023
Q1 		$6.34K Hold
46
– – ﹤0.01% 835
2022
Q4 		$5.96K Buy
+46
New +$5.33K ﹤0.01% 788

Other funds holding SRPT

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return